74 results
8-K
EX-10.2
PHIO
Phio Pharmaceuticals Corp
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option
8-K
EX-10.1
rp1 qtbl13tvd82wywa
2 Jun 23
Phio Pharmaceuticals Announces $4 Million Concurrent Registered Direct
4:30pm
8-K
EX-10.1
sdbpvzw
20 Apr 23
Phio Pharmaceuticals Announces $2 Million Registered Direct
2:53pm
8-K
EX-10.1
h8c9griq
17 Feb 21
Entry into a Material Definitive Agreement
4:15pm
424B5
jb60ahnymsplr0tj
17 Feb 21
Prospectus supplement for primary offering
8:55am
8-K
EX-10.1
kdgv0
25 Jan 21
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-10.1
60a hn1oi7mmz9y6
2 Apr 20
Entry into a Material Definitive Agreement
5:00pm
424B5
cnq4thrqcam8tpk069ti
1 Apr 20
Prospectus supplement for primary offering
5:01pm
8-K
EX-1.1
8swpehj86l3p
13 Feb 20
Phio Pharmaceuticals Announces Pricing of $8.0 Million
5:25pm
424B4
f1qe8lmcr3 bsf6r
12 Feb 20
Prospectus supplement with pricing info
5:21pm